within Pharmacolibrary.Drugs.ATC.A;

model A07EA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.82,
    Cl             = 2e-06,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0004,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008833333333333334,
    Tlag           = 10.020000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A07EA03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Prednisone is a synthetic glucocorticoid drug commonly used as an anti-inflammatory and immunosuppressant in the treatment of conditions such as asthma, rheumatoid arthritis, allergic disorders, and autoimmune diseases. It is an oral prodrug, metabolized in the liver to its active form, prednisolone. Prednisone is widely approved and used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after oral administration.</p><h4>References</h4><ol><li><p>de Truchis, C, et al., &amp; Boyer, O (2023). Prednisolone pharmacokinetics after oral prednisone administration in paediatric patients with kidney transplant. <i>British journal of clinical pharmacology</i> 89(5) 1532–1540. DOI:<a href=\"https://doi.org/10.1111/bcp.15610\">10.1111/bcp.15610</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36510685/\">https://pubmed.ncbi.nlm.nih.gov/36510685</a></p></li><li><p>Sebbag, L, &amp; Mochel, JP (2020). Pharmacokinetics of Oral Prednisone at Various Doses in Dogs: Preliminary Findings Using a Naïve Pooled-Data Approach. <i>Frontiers in veterinary science</i> 7 571457–None. DOI:<a href=\"https://doi.org/10.3389/fvets.2020.571457\">10.3389/fvets.2020.571457</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33195563/\">https://pubmed.ncbi.nlm.nih.gov/33195563</a></p></li><li><p>Sebbag, L, et al., &amp; Mochel, JP (2019). Tear Fluid Pharmacokinetics Following Oral Prednisone Administration in Dogs With and Without Conjunctivitis. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 35(6) 341–349. DOI:<a href=\"https://doi.org/10.1089/jop.2019.0020\">10.1089/jop.2019.0020</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31070497/\">https://pubmed.ncbi.nlm.nih.gov/31070497</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A07EA03;
